Alison K. Esser
- Co-authors
- Michael D. HenryKatherine N. WeilbaecherMichael B. CohenJingyu XiangXinming SuFrancesca FontanaMichael H. RossMichael R. Miller
- Topics
- Protease and Inhibitor Mechanisms (3 papers)Nanoparticle-Based Drug Delivery (1 paper)Retinal Imaging and Analysis (1 paper)
- Cited by
- OncologyImmunologyCancer Research
- Partner nations
- United StatesRussiaGermany
In The Last Decade
Alison K. Esser
10 papers receiving 180 citations
Peers
Comparison fields: 5 of 48
- Molecular Biology 93
- Oncology 69
- Immunology 49
- Cancer Research 29
- Pulmonary and Respiratory Medicine 23
Countries citing papers authored by Alison K. Esser
This map shows the geographic impact of Alison K. Esser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison K. Esser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison K. Esser more than expected).
Fields of papers citing papers by Alison K. Esser
This network shows the impact of papers produced by Alison K. Esser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison K. Esser. The network helps show where Alison K. Esser may publish in the future.
Co-authorship network of co-authors of Alison K. Esser
This figure shows the co-authorship network connecting the top 25 collaborators of Alison K. Esser. A scholar is included among the top collaborators of Alison K. Esser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alison K. Esser. Alison K. Esser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 10 | |
| 2 | 31 | |
| 3 | 12 | |
| 4 | 49 | |
| 5 | 13 | |
| 6 | 33 | |
| 7 | 0 | |
| 8 | 11 | |
| 9 | 16 | |
| 10 | 6 | |
| 11 | [New light on the origin of cataract operation]. | 1 |
About Alison K. Esser
Alison K. Esser is a scholar working on Cancer Research, Immunology and Allergy and Immunology, having authored 11 papers that have together received 182 indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (3 papers), Nanoparticle-Based Drug Delivery (1 paper) and Retinal Imaging and Analysis (1 paper). The work is most often cited by research in Oncology (69 citations), Immunology (49 citations) and Cancer Research (29 citations). Alison K. Esser has collaborated with scholars based in United States, Russia and Germany. Frequent co-authors include Michael D. Henry, Katherine N. Weilbaecher, Michael B. Cohen, Jingyu Xiang, Xinming Su, Francesca Fontana, Michael H. Ross, Michael R. Miller, Charles F. Lynch and Kevin P. Campbell. Their work appears in journals such as Journal of Biological Chemistry, PLoS ONE and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.